tiprankstipranks
Advertisement
Advertisement

IMCR Stock Latest News

Immunocore presents updated results from Phase 1/2 trial of brenetafusp
The FlyImmunocore presents updated results from Phase 1/2 trial of brenetafusp
4d ago
IMCR
Immunocore Shareholders Back All Proposals at 2026 AGM
PremiumCompany Announcements
Immunocore Shareholders Back All Proposals at 2026 AGM
8d ago
8K
IMCR
Immunocore reports Q1 EPS 25c, consensus (26c)
PremiumThe Fly
Immunocore reports Q1 EPS 25c, consensus (26c)
28d ago
IMCR
Needham’s Gil Blum Reiterates Buy on Strong Execution, Robust Pipeline and Solid Cash Runway, Keeps $75 Price Target Unchanged
PremiumRatings
Needham’s Gil Blum Reiterates Buy on Strong Execution, Robust Pipeline and Solid Cash Runway, Keeps $75 Price Target Unchanged
29d ago
IMCR
Immunocore (IMCR): KIMMTRAK’s Durable Survival Benefit in Metastatic Uveal Melanoma Underpins Sustainable Growth and $100 Buy Rating
PremiumRatings
Immunocore (IMCR): KIMMTRAK’s Durable Survival Benefit in Metastatic Uveal Melanoma Underpins Sustainable Growth and $100 Buy Rating
1M ago
IMCR
Immunocore announces five-year overall survival data for Kimmtrak
PremiumThe FlyImmunocore announces five-year overall survival data for Kimmtrak
2M ago
IMCR
Immunocore: KIMMTRAK’s Durable Leadership in Metastatic Uveal Melanoma Underpins Buy Rating and $100 Target
Premium
Ratings
Immunocore: KIMMTRAK’s Durable Leadership in Metastatic Uveal Melanoma Underpins Buy Rating and $100 Target
2M ago
IMCR
Immunocore (IMCR): Clinical Momentum, Credible Management, and Industry Visibility Support Buy Rating
Premium
Ratings
Immunocore (IMCR): Clinical Momentum, Credible Management, and Industry Visibility Support Buy Rating
2M ago
IMCR
Qualcomm, Adobe downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Qualcomm, Adobe downgraded: Wall Street’s top analyst calls
3M ago
ECL
ETN
Immunocore downgraded to Hold from Buy at Jefferies
PremiumThe Fly
Immunocore downgraded to Hold from Buy at Jefferies
3M ago
IMCR
Immunocore: Strong KIMMTRAK Execution, Robust Late-Stage Pipeline, and Cash-Funded Catalysts Support Buy Rating and $100 Target
PremiumRatings
Immunocore: Strong KIMMTRAK Execution, Robust Late-Stage Pipeline, and Cash-Funded Catalysts Support Buy Rating and $100 Target
3M ago
IMCR
Immunocore: Sustained Kimmtrak Momentum and Pipeline Catalysts Support Buy Rating
PremiumRatings
Immunocore: Sustained Kimmtrak Momentum and Pipeline Catalysts Support Buy Rating
3M ago
IMCR
Immunocore reports Q4 EPS (60c), consensus (20c)
PremiumThe FlyImmunocore reports Q4 EPS (60c), consensus (20c)
3M ago
IMCR
IMCR Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
IMCR Earnings this Week: How Will it Perform?
3M ago
IMCR
Immunocore price target raised to $38 from $37 at Mizuho
Premium
The Fly
Immunocore price target raised to $38 from $37 at Mizuho
3M ago
IMCR
Immunocore announces R&D chief resignation and leadership reshuffle
PremiumCompany Announcements
Immunocore announces R&D chief resignation and leadership reshuffle
4M ago
8K
IMCR
Immunocore announces EVP, Research, Development Berman to depart
PremiumThe Fly
Immunocore announces EVP, Research, Development Berman to depart
4M ago
IMCR
Immunocore Sets 2026 Strategic Priorities for Melanoma Growth
PremiumCompany Announcements
Immunocore Sets 2026 Strategic Priorities for Melanoma Growth
5M ago
8K
IMCR
Immunocore announces 2026 strategic priorities
PremiumThe Fly
Immunocore announces 2026 strategic priorities
5M ago
IMCR
Immunocore price target raised to $40 from $36 at Morgan Stanley
PremiumThe FlyImmunocore price target raised to $40 from $36 at Morgan Stanley
5M ago
IMCR
Immunocore upgraded to Buy from Sell at UBS
Premium
The Fly
Immunocore upgraded to Buy from Sell at UBS
5M ago
IMCR
Immunocore Holdings Board Member Ranjeev Krishana Resigns
Premium
Company Announcements
Immunocore Holdings Board Member Ranjeev Krishana Resigns
6M ago
8K
IMCR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >